Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis.
Eun Sun KimByoung Soo KwonJong Sun ParkJae-Young ChungSoo Hyun SeoKyoung Un ParkJunghan SongSeonghae YoonJae Ho LeePublished in: British journal of clinical pharmacology (2021)
SLCO1B1 gene polymorphisms did not influence rifampicin concentrations and clinical outcomes in Korean patients with active pulmonary TB.